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ORIGINAL ARTICLE
Noninvasive Instrument-based Tests for Detecting and Measuring Vitreous 
Inflammation in Uveitis: A Systematic Review
Xiaoxuan Liu, MBChB a,b,c, Benjamin TK Huia, Christopher Way, MBChBd, Sophie Beese, MPHe, Ada Adriano, MSce, 
Pearse A Keane, MDf, David J Moore, PhDe, and Alastair K Denniston, PhD a,b,f,c
aOphthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; bAcademic Unit of Ophthalmology, Institute 
of Inflammation & Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham UK; cHealth Data Research UK, London, UK; 
dMusgrove Park Hospital, Taunton and Somerset NHS Foundation Trust, Taunton, UK; eInstitute of Applied Health Research, College of Medical and 
Dental Sciences, University of Birmingham, Birmingham UK; fNIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS 
Foundation Trust and UCL Institute of Ophthalmology, UK
ABSTRACT
Purpose: This systematic review aims to identify instrument-based tests for quantifying vitreous inflam-
mation in uveitis, report the test reliability and the level of correlation with clinician grading.
Methods: Studies describing instrument-based tests for detecting vitreous inflammation were identified 
by searching bibliographic databases and trials registers. Test reliability measures and level of correlation 
with clinician vitreous haze grading are extracted.
Results: Twelve studies describing ultrasound, optical coherence tomography (OCT), and retinal photo-
graphy for detecting vitreous inflammation were included: Ultrasound was used for detection of disease 
features, whereas OCT and retinal photography provided quantifiable measurements. Correlation with 
clinician grading for OCT was 0.53–0.60 (three studies) and for retinal photography was 0.51 (1 study). 
Both instruments showed high inter- and intra-observer reliability (>0.70 intraclass correlation and 
Cohen’s kappa), where reported in four studies.
Conclusion: Retinal photography and OCT are able to detect and measure vitreous inflammation. Both 
techniques are reliable, automatable, and warrant further evaluation.
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Vitreous inflammation, or vitritis, is a clinical manifestation 
commonly found in posterior-segment involving uveitis. It is 
the hall-mark of intermediate uveitis, but is also common in 
panuveitis and may occur in posterior uveitis.1,2 Infiltration 
of the vitreous body with inflammatory cells and proteinac-
eous exudates gives a characteristic hazy appearance, redu-
cing the clarity of structures behind it (the optic disc and 
retinal vessels) during fundoscopy.3 The clinical standard for 
measuring vitreous haze has been the National Eye Institute 
vitreous haze (NEI VH) scale since the Standardization of 
Uveitis Nomenclature (SUN) Workshop in 2005.1 Prior to 
the SUN workshop, three grading systems existed.2,4,5 The 
NEI VH scale is a 6-point grading system for estimating the 
vitreous clarity as seen through indirect ophthalmoscopy and 
is also referred to as the National Institute for Health (NIH) 
or Nussenblatt scale.1,2 The clinician’s estimate is compared 
to a standardized set of photographs and given a score of 0, 
+0.5, +1, +2, +3, or +4 (Table 1). This grading system has 
been the widely accepted standard for clinical assessment in 
routine care and for assessing disease outcomes in clinical 
trials.6–8 It has been adopted as part of composite measures 
of disease outcome for uveitis, alongside other markers of 
inflammation such as anterior chamber cells/flare, central 
macular thickness, visual function, and quality of life.9,10 
However, there are drawbacks to clinician grading. Firstly, 
this method is subjective with only moderate interobserver 
agreement, even when assessed by experienced uveitis 
specialists.11,12 Secondly, the grading scale is non- 
continuous and non-linear, with large steps between each 
grade. Lastly, the system is poorly discriminatory for low 
levels of vitreous inflammation, where the need for sensitive 
detection of inflammatory activity to allow early clinical 
intervention, is greatest.13
More recently, measuring vitreous inflammation using 
instrument-based systems such as imaging devices has 
been proposed as a solution to some of these challenges. 
Several instruments, including fundus photography, ultra-
sound, and optical coherence tomography (OCT) have 
been used to visualize the vitreous body. These instru-
ment-based methods have the theoretical advantage of 
being objective and automatable, and the changes detect-
able by each could be employed as surrogate measures of 
vitreous inflammation. This systematic review aims to 
identify all non-invasive, instrument-based tools (hereon 
referred to as index tests) with the ability to detect and 
measure vitreous inflammation in uveitis, and report the 
level of correlation between index tests and clinician 
grading, as well as the index tests’ reliability.
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Methods
This systematic review is reported according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) statement.14 The methodology was specified in 
advance and the protocol registered with PROSPERO 
(CRD42017084168).15 Our search seeks to identify all index 
tests for detecting and quantifying vitreous inflammation. 
Where index tests were compared against a clinician grading 
system, the level of correlation was extracted. Any evaluation of 
test reliability, such as intra- and inter-observer reliability was 
also extracted.
Search strategy
We combined free text terms and index terms reflecting the 
pathological finding of interest, ‘vitreous haze’ or ‘vitritis’ and 
the disease context ‘uveitis,’ ‘inflammation,’ ‘blood-retinal bar-
rier,’ and ‘leak’ where possible (search strategy available in 
Supplementary Materials). Database searches were carried 
out in MEDLINE, Embase, Cochrane Controlled Register of 
Trials (CENTRAL), Center for Reviews and Dissemination 
Database (Health Technology Assessments and the Database 
of Abstracts and Reviews of Effects), Clinicaltrials.gov, WHO 
International Clinical Trials Registry Platform (ICTRP portal), 
British Library’s ZETOC, Conference Proceedings Citation 
Index (Web of Science), British Library Ethos, ProQuest and 
OpenGrey. We searched all databases from inception to 
December 4, 2019, with no date or language restrictions. We 
manually searched citations of review articles and included 
studies to identify additional relevant articles.
Study selection
Two reviewers independently assessed study eligibility and 
resolved disagreements by consensus or by referral to a third 
reviewer. Studies were eligible if they described one or more 
index tests for detecting and measuring vitreous inflammation. 
Studies were not excluded based on the basis of subject age, 
gender, ethnicity, underlying etiology, or disease activity status. 
Animal studies and studies involving only healthy participants, 
single case reports, commentaries, and opinion articles were 
excluded.
Data extraction
Two reviewers independently extracted data using a pre- 
specified data extraction sheet and resolved any discrepancies 
through consensus and referral to a third reviewer when 
needed. Data extracted included study design, population char-
acteristics and disease phenotype, details of the index and 
reference tests, and outcomes relating to correlation between 
the two tests and test reliability. The full list of extracted items 
can be found in Table 2.
Risk of Bias Assessment
Relevant features of the Quality Assessment of Diagnostic 
Accuracy Studies tool (QUADAS-2) were used to assess for bias 
in the studies. The assessment considered patient selection (if the 
patients receiving the index and reference tests were representa-
tive of uveitis patients and the spectrum of uveitic subtypes), index 
test (if the index test was interpreted without knowledge of the 
reference test), reference test (if the reference test was interpreted 
without knowledge of the index test) and flow and timing (if all 
patients received both tests within an appropriate time interval – 
within same day assessment was deemed sufficient to ensure the 
inflammatory status of the eye had not changed). Not all elements 
of QUADAS-2 were applicable. For example, “whether the refer-
ence standard is likely to correctly quantify the target disease 
(vitreous inflammation)” would be marked unclear for all studies, 
due to the known poor reliability of clinician grading. As 
QUADAS-2 is only applicable for studies comparing an index 
test to reference test, the assessment was only carried out in studies 
evaluating correlation between the two tests and not in studies 
evaluating index test reliability.
Data analysis
For each index test, we tabulated the extracted information and 
provided a narrative synthesis of methodological characteris-
tics and index tests evaluated. Studies which compared index 
test measurements with a reference test (such as clinician 
grading) and reported a correlation coefficient were included 
in the analysis. In these studies, where confidence intervals for 
correlation coefficients were not reported, correlation coeffi-
cients were normalized using Fisher’s Z transformation for 
meta-analysis and back transformed and presented on 
a forest plot for visualization only. All statistical analyses 
were performed using Stata Statistical Software (Release 15. 
College Station, TX: StataCorp LP). Meta-analysis was not 
performed for test correlation or reliability due to heterogene-
ity between studies.
Results
Results of the Search
The study selection process is summarized in the PRISMA flow 
diagram (Figure 1).
The search yielded 7122 unique bibliographic records after 
removal of duplicates. Of these, 7100 were excluded based on 
screening of titles and abstracts. The large number of excluded 
records was due to the unrestrictive nature of the search strategy, 
Table 1. Standardization of uveitis nomenclature/Nussenblatt photographic grading 
of vitreous hazea
Grade Description
0 No evidence of vitreal haze
Trace/0.5+ Slight blurring of optic disc margin
1+ Obscured view but definition to optic nerve head and retinal 
vessels
2+ Obscured view but definition to retinal vessels
3+ Optic nerve head visualized but borders are very blurry
4+ Obscured fundal view
aNussenblatt et al. Standardization of Vitreal inflammatory Activity in 
Intermediate and Posterior Uveitis. Ophthalmology. 1985;92(4). Adopted with 
minor modifications by Jabs et al. Standardization of uveitis nomenclature for 
reporting clinical data. Results of the First International Workshop. Am 
J Ophthalmol. 2005;140(3).

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6 X. LIU ET AL.
which was deliberately wide, to ensure full capture of all poten-
tially relevant technologies. The remaining 22 articles were 
reviewed in full text and further 10 articles were excluded. The 
reasons for exclusion were due to not matching the criteria for 
outcome (n = 6) or target population (n = 4). Twelve articles 
were included; two studies compared an index test with 
a clinician grading system, two reported test reliability, and 
two did both. Six studies described index tests but did not report 
correlation with clinician grading or index test reliability 
(Table 2).
Participants’ characteristics and study design
The 12 studies included a total of at least 840 participants16-25 
(two studies did not report the number of participants26,27) and 
at least 846 eyes (one study did not report the number of 
eyes.23) The studies were published between 1977 and 2019. 
Four studies were conducted prospectively16,17,24,25 and eight 
were retrospective.18-,23-,26-,27 Only five studies reported 
gender, with 29% of participants (n = 149) being male.16,17,22- 
24 The age of participants in studies ranged from 12 to 
75 years.16,17,19-25 Five studies included mixed etiologies, 
including toxoplasmosis, sarcoidosis, Behcet’s disease, 
Birdshot chorioretinopathy, pars planitis, Vogt-Koyanagi- 
Harada disease, multiple sclerosis, tubulointerstitial nephritis 
and uveitis syndrome, Reiter’s syndrome, multifocal retinitis, 
serpiginous choroiditis, idiopathic retinal vasculitis, sympa-
thetic ophthalmia, and Dengue retinitis.19–22,24 Two studies 
were narrower in their inclusion criteria with one study includ-
ing intermediate uveitis only17 and the other including patients 
with multiple sclerosis only23. Five studies did not specify the 
underlying etiology of participants.16,25-27
Clinical reference test
Six out of 12 studies did not compare an index test against 
a comparator.17,22-26 One study compared ultrasound biomi-
croscopy against qualitative features on slit-lamp 
Figure 1. PRISMA flow diagram.
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fundoscopy.16 Four studies compared OCT19-21 and retinal 
photography27 against the NEI VH scale only, and one study 
compared retinal photography against both NEI VH scale and 
a photographic scale called the Miami scale (described in next 
section).27
Instruments for detecting and quantifying vitreous 
inflammation
Three types of technologies with the ability to detect and 
quantify vitreous inflammation were identified from the 12 
studies: ultrasound, retinal photography, and OCT.
Three studies employed ultrasound. One study used an A-scan 
instrument, model 7100A (Kretztechnik, Austria) with 
a transducer of 6 MHz/S mm25 and two studies used ultrasound 
biomicroscopy (the UBM 840 (Zeiss-Humphrey, San Leandro, 
CA, USA) with a 50 MHz probe in one study16 and the Model P45 
(Paradigm Medical Industries, Salt Lake City, Utah, USA) with 
a 50 MHz probe plus the Cinescan S (Quantel Medical, 
Clermonth-Ferrand, France) with a 20 MHz immersion open 
probe in another study.17) The images in all three studies were 
interpreted manually and qualitatively, by the operator, in real- 
time.
Three studies used retinal photography. Davis et al. 
developed a 9-point scale using calibrated Bangerter filters 
to blur fundus photographs, originally acquired using 30⁰ 
Zeiss fundus camera model FF4 (Carl Zeiss Meditec Inc, 
Pleasanton, California, USA) with a Nikon film camera 
(Nikon Instruments Inc, Melville, New York, USA).26 This 
9-point scale is known as the Miami scale and is designed 
to be a reference for manual clinician grading of fundus 
photographs. The authors tested the use of this reference 
scale using film fundus photographs from an imaging 
archive (unspecified camera and system). Madow et al. 
used fundus photographs originally acquired as color film 
slides for the MUST trial12 and digitized them using Nikon 
Coolscan film scanner (Nikon, Inc, Melville, New York, 
USA) at 300 dpi and saved as TIFF format.18 Madow 
et al. used the Miami scale developed by Davis et al. to 
grade the severity of vitreous haze in these photographs.18 
Passaglia et al. applied an automated retinal photography 
analysis software to grade fundus photographs from 
a clinical trial library (unspecified source, camera, and 
system) according to the NEI VH and Miami VH scales.27
Six studies used OCT. Five studies used the Heidelberg 
SPECTRALIS OCT19,20,22-24 and one used the Cirrus HD- 
OCT (Carl Zeiss Meditec, Dublin, California, USA).21 Two 
studies used the same semi-automated image analysis techni-
que (custom OCTOR software),19,22 two used the same fully 
automated image analysis technique (custom VITAN, which 
employs the same principles of pixel intensity as OCTOR, 
requires no manual input other than confirmation of the 
selected vitreous area)20,23 and one study used manual analysis 
of OCT images using a subjective observer-based grading sys-
tem consisting of grades 0–2, where grade 0 was ‘not visible,’ 
grade 1 was ‘barely visible,’ and grade 2 was ‘clearly visible.24
Index test reliability
Four studies reported index test reliability using varying meth-
odologies. Davis et al. reported an intraclass correlation (ICC) 
of 0.88 between two observers grading fundus photographs 
against the 9-point Miami scale.26 Madow et al. reported an 
inter-observer ICC of 0.87 and an intra-observer ICC of 
between 0.84 and 0.93 against the Miami scale.18 Keane et al. 
used Bland–Altman plots to assess interobserver variability and 
reported a median 95% limits of agreement (LoA) of 0.0353 for 
all OCTs, 0.0450 in OCTs of uveitic eyes with vitreous haze and 
0.0226 for OCTs of healthy eyes or uveitic eyes without vitr-
eous haze. They reported the variance ratio (F statistic) as non- 
significant between groups, suggesting the measurement var-
iance was similar in eyes with and without vitreous 
inflammation.19 Mahendradas et al. reported interobserver 
agreement as Cohen’s kappa >0.7 for all four tested techniques 
(standard OCT, enhanced vitreous imaging, enhanced depth 
imaging, and combined depth imaging).24
Correlation between index tests and the clinical reference 
test: Slit-lamp based clinician grading
Four studies reported correlation between an index test and 
clinician grading of vitreous inflammation (three studies using 
OCT19-21 and one study using retinal photography.18) All stu-
dies reporting correlation used the NEI VH scale as 
a comparator. The total number of participants included in 
these four studies was 307 (430 eyes). Spearman’s r was used by 
all studies except by Madow et al. to measure the association 
between index test measurements and the NEI VH scale. The 
level of correlation between OCT measurements and the NEI 
VH scale using the semi-automated OCTOR software was 
0.53–0.57,19,21 whereas for the fully automated VITAN soft-
ware correlation was marginally higher at 0.59–0.60.20,28 Both 
studies by Keane et al., reporting the use of OCTOR and 
VITAN, used the same retrospective dataset of images. The 
level of correlation between manual grading of retinal photo-
graphs (using the Miami scale) versus clinician examination 
(using the NEI VH scale) was reported as r = 0.51. The correla-
tion between index tests and the NEI VH scale are shown in 
Figure 2. None of the four studies reported confidence intervals 
for correlation coefficients and those shown in the forest plot 
were estimated using sample size and correlation coefficient. 
Passaglia et al. measured agreement between automated fundus 
photography grading (using the Miami scale) and clinician 
grading, rather than correlation. They report exact agreement, 
agreement within one level and agreement within two levels of 
0.61, 0.78, and 0.80, respectively, against clinician grading 
using the NIH scale and 0.67, 0.82, and 0.84, respectively, 
against the clinician grading using the Miami scale.27
Risk of Bias Assessment
The patient cohorts in the correlation studies were a mixture of 
uveitis etiologies with a low risk of spectrum bias, except in the 
retinal photography study by Madow et al., where the risk was 
not assessable as the underlying etiology was not reported.18 
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Other than Madow et al., all studies used automated/semi- 
automated systems to quantify vitreous haze; therefore, it was 
assumed there was no potential influence from knowledge of 
the clinician grading. All studies used previously recorded 
clinician grading (from clinical care or clinical trials data), 
therefore there was no possibility that the reference test could 
have been influenced by the index test, which was conducted 
afterward. Madow et al. did not report whether the fundus 
photograph readers were blinded to the clinician grading 
results. Although the time interval between index and reference 
tests were not explicitly reported by any of the studies, it is 
presumed that clinician grading and the images acquired were 
performed on the same visit in all studies, even if image 
analysis for index tests were done at a later date.
Study heterogeneity
After accounting for overlap between studies in terms of simi-
lar imaging techniques and duplicated patient cohorts, there 
was considerable heterogeneity between the methodology and 
populations across the included studies. Given this level of 
heterogeneity, we have not performed any meta-analysis of 
correlation or test reliability for index tests.
Discussion
This is the first systematic review for identifying noninvasive 
instrument-based tests for detecting and measuring vitreous 
inflammation in uveitis. Three technologies were found: ultra-
sound, retinal photography, and OCT. Ultrasound remains 
primarily for qualitative assessment of features in the vitreous 
body and has not been shown to quantify inflammation. 
Retinal photography and OCT have demonstrated the most 
potential as methods for quantifying vitreous inflammation 
through automated and semi-automated means of image ana-
lysis. However, only 12 studies have been undertaken and even 
fewer provided sufficient evidence on test reliability or correla-
tion with clinician grading.
Davis et al. and Madow et al. reported good interobserver 
reliability (ICC>0.84) and moderate correlation (r = 0.51) of 
manual grading using retinal photography (assessed using the 
Miami scale).18,26 This photographic method introduces two 
advantages beyond the traditional indirect biomicroscopic 
approach (assessed against the NEI VH scale). Firstly, it cap-
tures an adequate view of the fundus and removes the varia-
bility introduced by the level of the indirect biomicroscopy 
skills of the examiner. Secondly, it is based on a 9-point scale 
rather than the 6-point NEI VH scale, allowing smaller differ-
ences to be captured between grades. The automated retinal 
photography technique applied by Passaglia et al. brings added 
objectivity beyond the direct biomicroscopic assessment of the 
NEI VH scale or the original subjective photograph-to- 
photograph comparison of the Miami grading. On the other 
hand, the OCT-based technique utilizes signal intensity 
detected in the vitreous, to derive a measure of light reflectivity 
as a continuous variable. The ability to detect vitreous reflec-
tivity on a continuous scale means the OCT-based method may 
potentially offer sensitivity to even smaller, but potentially 
clinically significant, changes in vitreous inflammation.
Whilst automation of image analysis may improve reliabil-
ity, we did not find that it consistently improves correlation 
with clinician grading. The fully automated VITAN OCT algo-
rithm was tested on the same dataset as the semi-automated 
OCTOR algorithm and showed marginally higher correlation 
when compared to the NEI VH grade (r = 0.60 versus 0.57).20 
Manual grading of retinal photography showed moderate cor-
relation (r = 0.51)18 when compared to the NEI VH scale, 
similar to the moderate agreement reported for fully auto-
mated photographic grading (Cohen’s K = 0.61).27
Strengths and limitations of the review
This review represents the first systematic evaluation of tech-
nologies for measuring vitreous inflammation in uveitis. The 
search strategy was designed to be highly sensitive, using 
a broad range of databases, including conference proceedings, 
dissertation databases and the grey literature. This review also 
has several limitations. An issue in undertaking systematic 
reviews of correlation between assessment methods is the 
absence of an adequate specific tool for assessing risk of bias 
in studies. We have used relevant elements of the QUADAS-2 
tool for risk of bias assessment in test accuracy studies for the 
correlation studies only, where one test was being compared 
against another. However, this method of assessing risk of bias 
could not be applied to include studies which only evaluated 
one test (i.e. for index test reliability). Second, although we 
included all studies reporting instruments with the potential to 
detect and measure vitreous inflammation, the data extraction 
and analysis were focused on test reliability or correlation with 
the clinical standard. As a result, two studies that provide 
evidence of the clinical validity and value of new techniques 
were not discussed in detail.22,23 These include Sreekantam 
Figure 2. Level of correlation between index tests and clinician grading (SUN/NEI/Nussenblatt vitreous haze scale). RPE: retinal pigmented epithelium, OCT: optical 
coherence tomography. *Keane 2015 uses VITAN, an automated version of the previously published OCTOR software. Two variations of the same technique are 
presented: vitreous:RPE signal ratio and vitreous:RPE textural ratio.** Keane 2014 and Keane 2015 used the same cohort of patients for both studies.
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et al.’s study which reported a highly statistically significant 
reduction of OCT-based vitreous signal (using OCTOR) pre- 
and post-injection of sub-tenon’s triamcinolone in patients 
with uveitic macular edema, demonstrating the potential clin-
ical utility of this technique for detecting treatment response 
and its potentially superior sensitivity for measuring change 
over the clinician based grading system; however, this study 
did not include NEI VH scale as a comparator.22 Coric et al. 
also explored whether a difference in vitreous intensity could 
be detected in patients with multiple sclerosis versus healthy 
controls, but did not find a measurable difference; again this 
study did not include NEI VH scale as a comparator.23 
Additional imaging techniques such as ultra-wide field fundus 
photography (using the Optos ultra-wide field camera) have 
also been used to detect presence and absence of vitreous haze 
through manual observation.29 Third, the focus of this review 
was on correlation with the reference test. Whilst correlation is 
helpful in early validation, it is limited to demonstrating agree-
ment and non-inferiority to the comparator. From correlation, 
it is not possible to determine if the index test is more accurate 
than the reference test. To determine accuracy, a more reliable 
reference test than the NEI VH scale is required, such as the use 
of invasive vitreous sampling to determine the level of protein 
and cellular infiltrates in the vitreous. Due to risks involved, it 
is unlikely that vitreous sampling will be ethically justifiable in 
routine practice. In the absence of a reliable reference test, 
future work could compare the ability of index tests versus 
clinician grading to detect changes in inflammation, such as 
the pre- and post-treatment comparison Sreekantam et al. 
conducted.22 The ability to demonstrate higher sensitivity to 
small changes as well as stronger association with other inflam-
matory markers (such as central macular thickness) and visual 
function, would provide further evidence of accuracy in mea-
suring the true disease state.
Limitations of the evidence
Firstly, due to the small number of included studies and het-
erogeneity in study design, meta-analyses of correlation or 
reliability were not possible. Several studies were conducted 
by the same author groups and presented sequential updates of 
the same technique using different approaches to image analy-
sis, including automation.20,27 Most studies used retrospec-
tively collected images, with several applying newer analysis 
techniques to the same image set. Incomplete reporting and 
varying methodology of the included studies also meant we 
were unable to pool estimates of correlation between index and 
reference tests. Secondly, authors sometimes reported correla-
tion coefficients estimated from a mixed cohort of uveitic and 
healthy eyes. With the exception of Madow et al., where only 
uveitic eyes were included in the study, all other studies report-
ing correlation coefficients were a mixture of healthy and 
uveitic eyes.19–21 It was not possible to separate the two cohorts 
as correlation was reported at an aggregated level in all cases. 
On the other hand, all studies reporting intra/inter-observer 
reliability included uveitic eyes only. Thirdly, of those studies 
that reported NEI VH grading, no patients for OCT and only 
one patient for retinal photography had grade 4+.18 It could be 
that in dense vitreous haze, neither OCT nor photography can 
successfully acquire a usable image and such cases could have 
been excluded on the basis of poor image quality. However, it is 
unclear how those index tests performed in the most severe 
grades of vitreous inflammation.
Clinical relevance and impact
Of the instrument-based tests identified, OCT and retinal 
photography are presented with the most supporting evidence 
in this review. Both instruments offer the attractiveness of 
being technologies already widely available in ophthalmic 
clinics. Additionally, both techniques can be combined with 
automated image analysis techniques. OCT additionally offers 
a measurement which can be continuous and it has also been 
shown to be sensitive to respond to treatment.22 At this stage 
there are only a few reports identified for either technology and 
these reports were mostly retrospective studies with small 
numbers of subjects. As noted earlier very few patients with 
severe vitritis are included in these studies, and it is difficult to 
draw conclusions on the validity of both instruments in the 
most severe levels of inflammation. It could be argued that, 
where inflammation is obviously detectable through clinical 
examination, there is less additional value of quantification 
by a noninvasive imaging technique. However, clearly, the 
ideal scenario is to have a technique that is sensitive to changes 
at both ends of the scale, including detecting worsening or 
improvement in severe inflammation.
Another major consideration is around generalizability of 
the study findings in the presence of ocular co-pathology. Of 
particular concern is media opacity such as cataract, which may 
cause a similar hazy appearance on fundoscopy and which 
could degrade image quality on both retinal photography and 
OCT. Given cataracts are a major complication of chronic 
intraocular inflammation and ocular steroid therapy, many 
patients with posterior uveitis have cataracts.30 In the included 
studies of this review, only Davis et al. reported the exclusion of 
subjects with cataracts.26 Zarranz-Ventura et al. assessed the 
use of OCT of patients with uveitis, which also included pseu-
dophakia and patients who had undergone vitrectomy. They 
demonstrated no observable difference in the measurement for 
each of these groups compared to phakic and non- 
vitrectomised eyes, respectively.21
An important area for future work is to evaluate the rela-
tionship between instrument-based measures and visual func-
tion. Sreekantam et al. reported a correlation coefficient of 0.70 
between VIT/RPE-relative intensity and visual acuity, 
a stronger correlation than was demonstrated when the same 
OCTOR technique was compared to the NEI VH grading by 
Keane et al. (r = 0.60).19,22 However, this is not a direct com-
parison due to different subjects in each study. No other studies 
explored the association between the index test measurements 
and visual acuity or any other measure of visual function. 
Whilst the relationship of visual function to inflammatory 
activity is complex, often being delayed and indirect, it is 
worthy of exploration. These tests will be of greatest value if 
their use enables better control of inflammation, such that 
vision is maintained in the immediate and long term. It is 
worth noting that the importance of demonstrating clinical 
validity through association with visual function was 
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emphasized by regulatory bodies at the American Uveitis 
Society workshop at the University of California Los 
Angeles (UCLA) in March 2019 on Objective Measures of 
Intraocular Inflammation for Use in Clinical Trials.31
If the unreliability of the current reference standard is limit-
ing the evaluation and adoption of emerging techniques, are 
there any other techniques we should consider as a reference 
test? As previously discussed, direct sampling of vitreous is 
unlikely to be ethically justifiable unless it is being done for 
diagnostic purposes. More invasive tests to quantify vitreous 
inflammation also exist but are largely unused. Vitreous fluor-
ophotometry is an intravenous fluorescein-based imaging 
technique which can quantify leakage of dye from the blood- 
retinal-barrier (BRB) and has been used in the assessment of 
inflammation of the posterior segment.32 Vitreous fluoropho-
tometry measures leakage by measuring the degree of fluores-
cence throughout the eye at defined axial points before and 
after the intravenous injection of fluorescein. It relies on the 
principle that the amount of leakage is proportional to the 
degree of BRB breakdown. However, due to its invasive nature, 
vitreous fluorophotometry is rarely performed and for the 
most part, has been used as an experimental technique rather 
than for clinical care.33 Nonetheless, it is worth considering 
that invasive tests like fluorophotometry may be more direct 
measures of inflammatory activity and may serve as better 
reference tests with which to validate newer noninvasive tests. 
Assuming invasive approaches are not undertaken, evidence 
supporting new techniques and eventual adoption as 
a ‘reference standard’ is likely to depend on demonstrating 
high test reliability, strong association with other evidence of 
inflammation (such as macular thickness, presence of vitreous 
cells and other vitreous inflammatory infiltrates, presence of 
retinal vasculitis and vascular leakage and new active inflam-
matory lesions), and association with visual function (recog-
nizing that this may not be direct or immediate).
Conclusion
Non-invasive instrument-based tests for measuring vitreous 
inflammation have the potential to improve reliability and 
speed compared to clinician grading using indirect ophthalmo-
scopy. Retinal photography and OCT are two promising tech-
nologies with the potential to quantify vitreous inflammation; 
however, further evidence beyond the proof-of-concept studies 
identified by this review are required to demonstrate clinical 
utility. Further evaluation in prospective studies should explore 
association with other measures of posterior-segment inflam-
mation as well as visual function.
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